✦ LIBER ✦

Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia

✍ Scribed by Ariel Berger; Ellen Dukes; Bill McCarberg; Marty Liss; Gerry Oster

Book ID: 117321507
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 88 KB
Volume: 25
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(03)80335-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of opioid analgesics in patients wit

Use of opioid analgesics in patients with postherpetic neuralgia (PHN) first treated with gabapentin or pregabalin

✍ P. Johnson; L. Becker; R. Halpern; M. Sweeney; R. Dworkin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

(722): Initial use of pregabalin and gab

(722): Initial use of pregabalin and gabapentin in patients with diabetic neuropathy or postherpetic neuralgia: Achieving the minimally effective dose

✍ M. Gore; N. Brandenburg; K. Tai; B. Stacey 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

(321) The effects of opioids and tricycl

(321) The effects of opioids and tricyclic antidepressants on pain-related catastrophizing in patients with postherpetic neuralgia

✍ J. Haythornthwaite; R. Edwards; L. Buenaver; C. Campbell; S. Raja 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Effect of a once-daily gastroretentive f

Effect of a once-daily gastroretentive formulation of gabapentin on the Brief Pain Inventory Scale scores in patients with postherpetic neuralgia

✍ M. Sweeney; B. Misha; M. Wallace; R. Freeman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

(387) Sensitivity analyses of the primar

(387) Sensitivity analyses of the primary efficacy endpoint in a phase 2 randomized, placebo-controlled study of gabapentin enacarbil (GEn) in patients with neuropathic pain associated with postherpetic neuralgia (PHN)

✍ Calkins, A.; Gudin, J.; Gidal, B.; Jaros, M.; Kim, R.; Shang, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Changes in cotherapies after initiation

Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis

✍ Vivian K. Kawai; Carlos G. Grijalva; Patrick G. Arbogast; Jeffrey R. Curtis; Dan 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 392 KB 👁 2 views